| Ytd | 43.34% | |
| 1y | 67.93% |
| Open | 34.27 | Prev Close | 33.93 | Low | 34.12 | High | 34.76 | Mkt Cap | 1.69B |
| Vol | 655.84K | Avg Vol | 1.15M | EPS | -0.21 | P/E | -163.99 | Forward P/E | 256.41 |
| Beta | 1.94 | Short Ratio | 2.66 | Inst. Own | 104.50% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 27.76 | 200-d Avg | 24.42 | 1yr Est | 32.11 |
BLFS News
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zack
Total revenue of $28.5 million, up 21% over Q2 2025 GAAP gross margin of 64% and non-GAAP adjusted g
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
RGEN's $1.5 billion BioLife acquisition aims to expand its cell therapy capabilities, adding biopres
Repligen NASDAQ: RGEN said it has signed a definitive agreement to acquire BioLife Solutions in a tr
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (
NEW YORK, July 22, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Ass
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price
MILWAUKEE, July 22, 2026 /PRNewswire/ -- Ademi LLP is investigating BioLife (NASDAQ: BLFS) for possi
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc.
Life sciences company Repligen Corporation (NASDAQ:RGEN) on Wednesday agreed to acquire cell process
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale
Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at
Fast-tracks Repligen's leadership and customer solution offering in high-growth cell therapy market
On May 28, 2026, BioLife Solutions Inc (BLFS) shares rose 3.1% to a current price of $25.25. This mo
BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zack
Total revenue of $27.5 million, up 25% over Q1 2025 GAAP gross margin and non-GAAP adjusted gross ma
The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026,
BioLife Solutions, Inc. (NASDAQ: BLFS - Get Free Report) shares crossed below its 200-day moving ave
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday